EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update JS Smolen, R Landewé, J Bijlsma, G Burmester, K Chatzidionysiou, ... Annals of the rheumatic diseases 76 (6), 960-977, 2017 | 5766 | 2017 |
Treating rheumatoid arthritis to target: recommendations of an international task force JS Smolen, D Aletaha, JWJ Bijlsma, FC Breedveld, D Boumpas, ... Annals of the rheumatic diseases 69 (4), 631-637, 2010 | 2911 | 2010 |
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update JS Smolen, RBM Landewé, JWJ Bijlsma, GR Burmester, M Dougados, ... Annals of the rheumatic diseases 79 (6), 685-699, 2020 | 2654 | 2020 |
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs JS Smolen, R Landewé, FC Breedveld, M Dougados, P Emery, ... Annals of the rheumatic diseases 69 (6), 964-975, 2010 | 2394 | 2010 |
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update L Gossec, JS Smolen, S Ramiro, M De Wit, M Cutolo, M Dougados, ... Annals of the rheumatic diseases 75 (3), 499-510, 2016 | 1152 | 2016 |
Update of EULAR recommendations for the treatment of systemic sclerosis O Kowal-Bielecka, J Fransen, J Avouac, M Becker, A Kulak, Y Allanore, ... Annals of the rheumatic diseases 76 (8), 1327-1339, 2017 | 1129 | 2017 |
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation CG Skorpen, M Hoeltzenbein, A Tincani, R Fischer-Betz, E Elefant, ... Annals of the rheumatic diseases 75 (5), 795-810, 2016 | 1099 | 2016 |
Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. M Cutolo, A Sulli, C Pizzorni, S Accardo The Journal of rheumatology 27 (1), 155-160, 2000 | 886 | 2000 |
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology F Buttgereit, JAP Da Silva, M Boers, GR Burmester, M Cutolo, J Jacobs, ... Annals of the rheumatic diseases 61 (8), 718-722, 2002 | 665 | 2002 |
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data JAP Da Silva, JWG Jacobs, JR Kirwan, M Boers, KG Saag, LBS Inês, ... Annals of the rheumatic diseases 65 (3), 285-293, 2006 | 644 | 2006 |
Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis M Cutolo, A Sulli, C Pizzorni, B Seriolo, RH Straub Annals of the rheumatic diseases 60 (8), 729-735, 2001 | 604 | 2001 |
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update JS Smolen, RBM Landewé, SA Bergstra, A Kerschbaumer, A Sepriano, ... Annals of the rheumatic diseases 82 (1), 3-18, 2023 | 581 | 2023 |
Epidemiology of chronic musculoskeletal pain MA Cimmino, C Ferrone, M Cutolo Best practice & research Clinical rheumatology 25 (2), 173-183, 2011 | 577 | 2011 |
Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity M Cutolo, A Sulli, S Capellino, B Villaggio, P Montagna, B Seriolo, ... Lupus 13 (9), 635-638, 2004 | 565 | 2004 |
Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study T Sokka, S Toloza, M Cutolo, H Kautiainen, H Makinen, F Gogus, V Skakic, ... Arthritis research & therapy 11, 1-12, 2009 | 561 | 2009 |
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases JN Hoes, JWG Jacobs, M Boers, D Boumpas, F Buttgereit, N Caeyers, ... Annals of the rheumatic diseases 66 (12), 1560-1567, 2007 | 561 | 2007 |
Mapping and predicting mortality from systemic sclerosis M Elhai, C Meune, M Boubaya, J Avouac, E Hachulla, A Balbir-Gurman, ... Annals of the rheumatic diseases 76 (11), 1897-1905, 2017 | 550 | 2017 |
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group J Avouac, J Fransen, UA Walker, V Riccieri, V Smith, C Muller, I Miniati, ... Annals of the rheumatic diseases 70 (3), 476-481, 2011 | 513 | 2011 |
Energy regulation and neuroendocrine–immune control in chronic inflammatory diseases RH Straub, M Cutolo, F Buttgereit, G Pongratz Journal of internal medicine 267 (6), 543-560, 2010 | 457 | 2010 |
Phase IIb dose‐ranging study of the oral JAK inhibitor tofacitinib (CP‐690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an … R Fleischmann, M Cutolo, MC Genovese, EB Lee, KS Kanik, S Sadis, ... Arthritis & Rheumatism 64 (3), 617-629, 2012 | 453 | 2012 |